IHT Wealth Management’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-18,090
Closed -$822K 1288
2025
Q4
$822K Sell
18,090
-1,313
-7% -$58.2K 0.02% 593
2025
Q3
$753K Buy
19,403
+2,715
+16% +$98.3K 0.02% 613
2025
Q2
$563K Sell
16,688
-4,064
-20% -$129K 0.02% 659
2025
Q1
$660K Sell
20,752
-1,325
-6% -$50.3K 0.02% 585
2024
Q4
$857K Buy
22,077
+5,769
+35% +$242K 0.03% 505
2024
Q3
$734K Buy
16,308
+5,118
+46% +$229K 0.02% 593
2024
Q2
$467K Sell
11,190
-13,750
-55% -$575K 0.02% 658
2024
Q1
$1.14M Buy
24,940
+2,238
+10% +$102K 0.05% 381
2023
Q4
$1.05M Sell
22,702
-985
-4% -$40.2K 0.05% 374
2023
Q3
$964K Buy
23,687
+610
+3% +$27.8K 0.05% 357
2023
Q2
$1.12M Buy
23,077
+2,685
+13% +$134K 0.06% 314
2023
Q1
$1M Buy
20,392
+5,859
+40% +$302K 0.06% 309
2022
Q4
$735K Buy
14,533
+4,534
+45% +$234K 0.05% 373
2022
Q3
$502K Buy
9,999
+1,030
+11% +$58.1K 0.04% 454
2022
Q2
$438K Buy
8,969
+6,437
+254% +$326K 0.04% 419
2022
Q1
$152K Buy
+2,532
New +$160K 0.01% 729

Other funds holding GNOM

IHT Wealth Management's GNOM Position: Q1 2026 in Review

IHT Wealth Management sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q1 2026, closing a stake of 18,090 shares — an estimated $822K sold.

IHT Wealth Management first reported a position in GNOM in Q1 2022 and held it in 16 quarters. The position peaked at $1.14M in Q1 2024. 40 funds tracked by Wall St. Rank hold GNOM as of Q1 2026.

  • IHT Wealth Management reported no remaining Global X Genomics & Biotechnology ETF position as of Q1 2026 after selling out during the quarter.
  • IHT Wealth Management sold 18,090 Global X Genomics & Biotechnology ETF shares in Q1 2026, an estimated $822K.
  • IHT Wealth Management first reported a position in Global X Genomics & Biotechnology ETF in Q1 2022 and held it in 16 quarters.
  • IHT Wealth Management's Global X Genomics & Biotechnology ETF position peaked at $1.14M in Q1 2024.
  • 40 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q1 2026.

Based on IHT Wealth Management's 13F filing for Q1 2026, filed 15 May 2026.